Valuation (10%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -28.03 | N/A |
| PEG Ratio (TTM) | -2.24 | N/A |
| P/S Ratio (TTM) | 5.83 | N/A |
| P/B Ratio (TTM) | 16.41 | N/A |
| P/FCF Ratio (TTM) | -91.31 | N/A |
| Price to 5YR AVG Earnings Ratio | -10.02 | N/A |
| Price to 5YR AVG FCF Ratio | -14.98 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -13.31% | N/A |
| ROE (TTM) | -69.54% | N/A |
| Net Profit Margin (TTM) | -21.21% | N/A |
| ROIC 5YR AVG | -42.68% | N/A |
Growth (82%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 6.81% | 21.00% | 22.33% |
| Revenue | 8.40% | 53.33% | 37.81% |
| Net Income | 6.20% | 9.91% | 14.24% |
| Cash Flow | -218.63% | 12.19% | 22.56% |
Health (30%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.15 | N/A |
| Quick Ratio (TTM) | 2.42 | N/A |
| D/E Ratio (TTM) | 2.23 | N/A |
| Interest Coverage (TTM) | 0.22 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | -2.27 | N/A |
| Shares Outstanding Growth 5YR AVG | 10.11% | N/A |